Playback speed
10 seconds
Five-Year Updates on Venetoclax + Obinutuzumab for Previously Untreated CLL: Clinical Learnings From the CLL14 Study
By
The University of Kansas Cancer Center
FEATURING
Marc Hoffmann
By
The University of Kansas Cancer Center
FEATURING
Marc Hoffmann
531 views
February 1, 2023
Login to view comments.
Click here to Login